The experimental antiviral drug Molnupiravir is expected to become available in Slovenia from tomorrow for the treatment of COVID-19, especially for vulnerable patients who have higher risk factors or underlying health issues.
The drug was originally developed to treat a different virus but showed strong results in fighting other viruses, such as influenza and Ebola.
It's name was inspired by the name of Thor's hammer, Mjolnir.
Voluntary vaccination of children aged between 5 and 11 is also expected to begin next week.
Komentarji so trenutno privzeto izklopljeni. V nastavitvah si jih lahko omogočite. Za prikaz možnosti nastavitev kliknite na ikono vašega profila v zgornjem desnem kotu zaslona.
Prikaži komentarje